US FDA

Cingulate and Indegene sign agreement for lead ADHD candidate CTx-1301

Read more

Glenmark, Cediprof partner to alleviate US amphetamine shortage

Read more

Strides’ Bangalore facility gets EIR from USFDA

Read more

Glenmark gets second tentative ANDA approval for Saxagliptin Tablets, 2.5 mg and 5 mg

Read more

NATCO announces ANDA filing for generic olaparib tablets in US

Read more

Sun Pharma gets US FDA nod for generic lenalidomide capsules

Read more

Lupin gets US FDA approval for Brivaracetam Tablets

Read more

US FDA declines to approve Y-mAbs’s paediatric cancer drug

Read more

Provention Bio diabetes drug to cost $13,850/vial

Read more

Eugia Pharma receives US FDA nod for Amphotericin B Liposome Injection

Read more